Cargando…

Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress

Hepatocytes are epithelial cells with highly specialized polarity. The disorder and loss of hepatocyte polarity leads to a weakness of cell adhesion and connection, the induction of epithelial–mesenchymal transition, and eventually the occurrence of hepatocellular carcinoma (HCC). Cluster of differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Meng, Wu, Jiao, Hao, Zhi‐Wei, Shang, Yu‐Kui, Xu, Jing, Nan, Gang, Li, Xia, Chen, Zhi‐Nan, Bian, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055794/
https://www.ncbi.nlm.nih.gov/pubmed/29356040
http://dx.doi.org/10.1002/hep.29798
_version_ 1783341249696104448
author Lu, Meng
Wu, Jiao
Hao, Zhi‐Wei
Shang, Yu‐Kui
Xu, Jing
Nan, Gang
Li, Xia
Chen, Zhi‐Nan
Bian, Huijie
author_facet Lu, Meng
Wu, Jiao
Hao, Zhi‐Wei
Shang, Yu‐Kui
Xu, Jing
Nan, Gang
Li, Xia
Chen, Zhi‐Nan
Bian, Huijie
author_sort Lu, Meng
collection PubMed
description Hepatocytes are epithelial cells with highly specialized polarity. The disorder and loss of hepatocyte polarity leads to a weakness of cell adhesion and connection, the induction of epithelial–mesenchymal transition, and eventually the occurrence of hepatocellular carcinoma (HCC). Cluster of differentiation 147 (CD147), a tumor‐related glycoprotein, promotes epithelial–mesenchymal transition and the invasion of HCC. However, the function of CD147 in hepatocyte depolarization is unknown. Here we identified that CD147 was basolaterally polarized in hepatocyte membrane of liver tissues and HepG2 cells. CD147 not only promoted transforming growth factor‐β1–mediated hepatocyte polarity loss but also directly induced endocytosis and down‐regulation of E‐cadherin which contributed to hepatocyte depolarization. Overexpression of CD147 induced Src activation and subsequently recruited ubiquitin ligase Hakai for E‐cadherin ubiquitination and lysosomal degradation, leading to decreases of partitioning defective 3 expression and β‐catenin nuclear translocation. This signal transduction was initiated by competitive binding of CD147 with integrin β1 that interrupted the interaction between the Arg‐Gly‐Asp motif of fibronectin and integrin β1. The specific antibodies targeting integrin α5 and β1 reversed the decrease of E‐cadherin and partitioning defective 3 levels induced by CD147 overexpression. In human liver tissues, CD147 polarity rates significantly declined from liver cirrhosis (71.4%) to HCC (10.4%). CD147‐polarized localization negatively correlated with Child‐Pugh scores in human liver cirrhosis (r = –0.6092, P < 0.0001) and positively correlated with differentiation grades in HCC (r = 0.2060, P = 0.004). HCC patients with CD147‐polarized localization had significantly better overall survival than patients with CD147 nonpolarity (P = 0.021). Conclusion: The ectopic CD147‐polarized distribution on basolateral membrane promotes hepatocyte depolarization by activation of the CD147–integrin α5β1–E‐cadherin ubiquitination–partitioning defective 3 decrease and β‐catenin translocation signaling cascade, replenishing a molecular pathway in hepatic carcinogenesis. (Hepatology 2018;68:317‐332).
format Online
Article
Text
id pubmed-6055794
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60557942018-07-30 Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress Lu, Meng Wu, Jiao Hao, Zhi‐Wei Shang, Yu‐Kui Xu, Jing Nan, Gang Li, Xia Chen, Zhi‐Nan Bian, Huijie Hepatology Original Articles Hepatocytes are epithelial cells with highly specialized polarity. The disorder and loss of hepatocyte polarity leads to a weakness of cell adhesion and connection, the induction of epithelial–mesenchymal transition, and eventually the occurrence of hepatocellular carcinoma (HCC). Cluster of differentiation 147 (CD147), a tumor‐related glycoprotein, promotes epithelial–mesenchymal transition and the invasion of HCC. However, the function of CD147 in hepatocyte depolarization is unknown. Here we identified that CD147 was basolaterally polarized in hepatocyte membrane of liver tissues and HepG2 cells. CD147 not only promoted transforming growth factor‐β1–mediated hepatocyte polarity loss but also directly induced endocytosis and down‐regulation of E‐cadherin which contributed to hepatocyte depolarization. Overexpression of CD147 induced Src activation and subsequently recruited ubiquitin ligase Hakai for E‐cadherin ubiquitination and lysosomal degradation, leading to decreases of partitioning defective 3 expression and β‐catenin nuclear translocation. This signal transduction was initiated by competitive binding of CD147 with integrin β1 that interrupted the interaction between the Arg‐Gly‐Asp motif of fibronectin and integrin β1. The specific antibodies targeting integrin α5 and β1 reversed the decrease of E‐cadherin and partitioning defective 3 levels induced by CD147 overexpression. In human liver tissues, CD147 polarity rates significantly declined from liver cirrhosis (71.4%) to HCC (10.4%). CD147‐polarized localization negatively correlated with Child‐Pugh scores in human liver cirrhosis (r = –0.6092, P < 0.0001) and positively correlated with differentiation grades in HCC (r = 0.2060, P = 0.004). HCC patients with CD147‐polarized localization had significantly better overall survival than patients with CD147 nonpolarity (P = 0.021). Conclusion: The ectopic CD147‐polarized distribution on basolateral membrane promotes hepatocyte depolarization by activation of the CD147–integrin α5β1–E‐cadherin ubiquitination–partitioning defective 3 decrease and β‐catenin translocation signaling cascade, replenishing a molecular pathway in hepatic carcinogenesis. (Hepatology 2018;68:317‐332). John Wiley and Sons Inc. 2018-03-23 2018-07 /pmc/articles/PMC6055794/ /pubmed/29356040 http://dx.doi.org/10.1002/hep.29798 Text en © 2018 The Authors. Hepatology published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Lu, Meng
Wu, Jiao
Hao, Zhi‐Wei
Shang, Yu‐Kui
Xu, Jing
Nan, Gang
Li, Xia
Chen, Zhi‐Nan
Bian, Huijie
Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
title Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
title_full Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
title_fullStr Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
title_full_unstemmed Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
title_short Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
title_sort basolateral cd147 induces hepatocyte polarity loss by e‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055794/
https://www.ncbi.nlm.nih.gov/pubmed/29356040
http://dx.doi.org/10.1002/hep.29798
work_keys_str_mv AT lumeng basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT wujiao basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT haozhiwei basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT shangyukui basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT xujing basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT nangang basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT lixia basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT chenzhinan basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress
AT bianhuijie basolateralcd147induceshepatocytepolaritylossbyecadherinubiquitinationanddegradationinhepatocellularcarcinomaprogress